The Bm86 Discovery: A Revolution in the Development of Anti-Tick Vaccines
Open Access
Abstract
The presence in nature of species with genetic resistance to ticks, or with acquired resistance after repeated tick infestations, has encouraged the scientific community to consider vaccination as an alternative to the unsustainable chemical control of ticks. After numerous attempts to artificially immunize hosts with tick extracts, the purification and characterization of the Bm86 antigen by Willadsen et al. in 1989 constituted a revolutionary step forward in the development of vaccines against ticks. Previously, innovative studies that had used tick gut extracts for the immunization of cattle against Rhipicepahalus microplus (previously named Boophilus microplus) ticks, with amazingly successful results, demonstrated the feasibility of using antigens other than salivary-gland-derived molecules to induce a strong anti-tick immunity. However, the practical application of an anti-tick vaccine required the isolation, identification, and purification of the responsible antigen, which was finally defined as the Bm86 protein. More than thirty years later, the only commercially available anti-tick vaccines are still based on this antigen, and all our current knowledge about the field application of immunological control based on vaccination against ticks has been obtained through the use of these vaccines.Keywords
This publication has 87 references indexed in Scilit:
- Exploring the use of an anti-tick vaccine as a tool for the integrated eradication of the cattle fever tick, Rhipicephalus (Boophilus) annulatusVaccine, 2012
- A novel tick antigen shows high vaccine efficacy against the dog tick, Rhipicephalus sanguineusVaccine, 2012
- Novel gene isolated from Caligus rogercresseyi: A promising target for vaccine development against sea liceVaccine, 2011
- Bm86 homologues and novel ATAQ proteins with multiple epidermal growth factor (EGF)-like domains from hard and soft ticksInternational Journal for Parasitology, 2010
- Two initial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus (Boophilus) microplusinduce similar reproductive suppression to three initial vaccinations under production conditionsBMC Veterinary Research, 2010
- Identification and characterization of Rhipicephalus (Boophilus) microplus candidate protective antigens for the control of cattle tick infestationsParasitology Research, 2009
- Gene silencing of the tick protective antigens, Bm86, Bm91 and subolesin, in the one-host tick Boophilus microplus by RNA interferenceInternational Journal for Parasitology, 2007
- An Antivector Vaccine Protects against a Lethal Vector-Borne PathogenPLOS Pathogens, 2006
- Identification of a Point Mutation in the para-Type Sodium Channel Gene from a Pyrethroid-Resistant Cattle TickBiochemical and Biophysical Research Communications, 1999
- Vaccination againstBoophilus microplus: Localization of antigens on tick gut cells and their interaction with the host immune systemExperimental and Applied Acarology, 1989